XML 46 R32.htm IDEA: XBRL DOCUMENT
v3.24.0.1

REVENUE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Revenue from Contract with Customer [Abstract] |
Schedule of disaggregation by revenue source | The following table presents the Company’s revenues disaggregated by revenue source:
|  | Year Ended December 31,
(In thousands) |  | 2023 |  | 2022 |  | 2021
Screening |  |  |  |  |  |
Medicare Parts B & C |  | $ | 701,400 |  |  | $ | 545,458 |  |  | $ | 438,646 |
Commercial |  | 992,244 |  |  | 743,238 |  |  | 569,944 |
Other |  | 171,057 |  |  | 136,007 |  |  | 53,718 |
Total Screening |  | 1,864,701 |  |  | 1,424,703 |  |  | 1,062,308 |
Precision Oncology |  |  |  |  |  |
Medicare Parts B & C |  | $ | 188,689 |  |  | $ | 197,327 |  |  | $ | 197,394 |
Commercial |  | 181,318 |  |  | 177,518 |  |  | 180,177 |
International |  | 153,277 |  |  | 117,738 |  |  | 109,913 |
Other |  | 105,826 |  |  | 108,905 |  |  | 74,192 |
Total Precision Oncology |  | 629,110 |  |  | 601,488 |  |  | 561,676 |
COVID-19 Testing |  | $ | 5,955 |  |  | $ | 58,088 |  |  | $ | 143,103 |
Total |  | $ | 2,499,766 |  |  | $ | 2,084,279 |  |  | $ | 1,767,087 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration